Biotechnology Law and Policy: Emerging Legal Issues, Cases and Materials
Autor Alessandro Stasien Limba Engleză Paperback – 22 mai 2024
This book covers an extensive range of issues raised by biotechnological advancements from a regulatory perspective. Written in a clear and readable style, its main objective is to give readers an idea of the relationship between biotechnology and law. Biotechnology advancements and their ethical, moral, economic, and social implications in different fields and the consequential normative demands on the law are crucial to this book. The chapters cover a multitude of themes and some of the most important legal issues arising in relation to biotechnology, including the historical development of a legal framework sufficient to protect public safety, the current biotechnology regulatory system, and the rules directing the primary agencies that regulate the products of biotechnology, namely the US Food and Drug Administration, the US Department of Agriculture, and the US Environmental Protection Agency, patents and IP rights in biotechnology, the regulation of human genome editingand its impact on health research, law and emerging genome editing technologies from recombinant DNA to CRISPR/Cas9, the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and legal issues arising from the use of genetic engineered plants and animals.
Presenting arguments that have been drawn from careful examination of various international documents and decisions made by legal institutions and judicial bodies, this book would be a valuable read for practitioners as well as academics of biotechnology law.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 442.26 lei 38-44 zile | |
Springer Nature Singapore – 22 mai 2024 | 442.26 lei 38-44 zile | |
Hardback (1) | 583.96 lei 6-8 săpt. | |
Springer Nature Singapore – 21 mai 2023 | 583.96 lei 6-8 săpt. |
Preț: 442.26 lei
Nou
Puncte Express: 663
Preț estimativ în valută:
84.65€ • 87.23$ • 71.46£
84.65€ • 87.23$ • 71.46£
Carte tipărită la comandă
Livrare economică 27 februarie-05 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789819921379
ISBN-10: 9819921376
Pagini: 149
Ilustrații: XI, 149 p. 1 illus.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 9819921376
Pagini: 149
Ilustrații: XI, 149 p. 1 illus.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Background and Overview of Biotechnology.- A Brief History of the FDA and its Role in Regulating Biotechnology Products.- Products of Biotechnology and IP System.- The Application of Patent Law to Biotechnology.- The Birth of the Biotechnology Industry.- The Limits and Challenges of Gene Editing.
Notă biografică
Alessandro Stasi is an Assistant Professor in Law at Mahidol University International College (MUIC), Thailand. He has authored several books and academic articles in leading international journals. Prior to joining Mahidol University International College, he held academic posts at Ramkhamhaeng University and King Mongkut’s Institute of Technology Ladkrabang. Alessandro Stasi also provides advice to private clients, international organizations, and non-governmental organizations. He read Law at the University of Naples Federico II, Italy, and subsequently completed an LLM with Merit and two PhD degrees at the University of Nice Sophia-Antipolis in France.
Textul de pe ultima copertă
This book covers an extensive range of issues raised by biotechnological advancements from a regulatory perspective. Written in a clear and readable style, its main objective is to give readers an idea of the relationship between biotechnology and law. Biotechnology advancements and their ethical, moral, economic, and social implications in different fields and the consequential normative demands on the law are crucial to this book. The chapters cover a multitude of themes and some of the most important legal issues arising in relation to biotechnology, including the historical development of a legal framework sufficient to protect public safety, the current biotechnology regulatory system, and the rules directing the primary agencies that regulate the products of biotechnology, namely the US Food and Drug Administration, the US Department of Agriculture, and the US Environmental Protection Agency, patents and IP rights in biotechnology, the regulation of human genome editing and its impact on health research, law and emerging genome editing technologies from recombinant DNA to CRISPR/Cas9, the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and legal issues arising from the use of genetic engineered plants and animals.
Presenting arguments that have been drawn from careful examination of various international documents and decisions made by legal institutions and judicial bodies, this book would be a valuable read for practitioners as well as academics of biotechnology law.
Caracteristici
Provides the most up-to-date analysis of the cases and materials related to legal and regulatory issues in biotechnology Covers a wide range of policy and regulatory issues that arise in biotechnology Offers a new perspective on biotechnology law by examining how it works in practice through key cases